Answers are grounded in this paper and cite their sources.
Editorial reviews anxiety treatments, highlights new medications, suggesting the need for better options.
Anxiety disorders are common and disabling. Current drugs have limited efficacy, notable side-effects and little innovation. This editorial briefly reviews past, current and emerging anxiolytic treatments, including psychedelic-assisted therapies, and highlights key themes. There remains a major need for improved medications to reduce disability and improve quality of life.
No takes yet. Share an insight, caveat, or question.
Peter M. Haddad (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: